Author(s): Frank Stegelmann, Martin Griesshammer, Steffen Koschmieder Abstract: P 700 Session topic: 16. Myeloproliferative neoplasms – Clinical Background: Therapeutic options to address anemia in patients (pts) with Myelofibrosis (MF) are limited. In our MPNSG-0109 trial investigating pomalidomide (POM) in MF with cytopenia, anemia was improved in 14-29% of pts treated with 0.5-2...
Pro zobrazení tohoto obsahu je třeba být přihlášen.